Cargando…
S-1–Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II Trial
Introduction: Intensive treatments can often not be administered to elderly patients with esophageal squamous cell carcinoma (ESCC), leading to a poorer prognosis. This multi-center phase II trial aimed to determine the toxicity profile and efficiency of S-1–based simultaneous integrated boost radio...
Autores principales: | Wang, Xin, Ge, Xiaolin, Wang, Xiaomin, Zhang, Wencheng, Zhou, Haiwen, Lin, Yu, Qie, Shuai, Hu, Miaomiao, Wang, Wei, Liu, Ke, Pang, Qingsong, Li, Minghe, Chen, Junqiang, Liu, Miaoling, Zhang, Kaixian, Li, Ling, Shi, Yonggang, Deng, Wei, Li, Chen, Ni, Wenjie, Chang, Xiao, Han, Weiming, Deng, Lei, Wang, Wenqing, Liang, Jun, Bi, Nan, Zhang, Tao, Liu, Wenyang, Wang, Jianyang, Zhai, Yirui, Feng, Qinfu, Chen, Dongfu, Zhou, Zongmei, Zhao, Yidian, Sun, Xinchen, Xiao, Zefen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484368/ https://www.ncbi.nlm.nih.gov/pubmed/32983991 http://dx.doi.org/10.3389/fonc.2020.01499 |
Ejemplares similares
-
Effectiveness of S-1–Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial
por: Wang, Xin, et al.
Publicado: (2023) -
Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis
por: Han, Weiming, et al.
Publicado: (2022) -
The impact of age on the survival outcomes and risk of radiation pneumonitis in patients with unresectable locally advanced non-small cell lung cancer receiving chemoradiotherapy
por: Zhang, Tao, et al.
Publicado: (2020) -
Clinical outcomes and radiation pneumonitis after concurrent EGFR‐tyrosine kinase inhibitors and radiotherapy for unresectable stage III non‐small cell lung cancer
por: Xu, Kunpeng, et al.
Publicado: (2021) -
Development and validation of a prediction model using molecular marker for long‐term survival in unresectable stage III non‐small cell lung cancer treated with chemoradiotherapy
por: Yang, Yufan, et al.
Publicado: (2021)